Vendetta Capital reaches to new heights, after connecting with Charged Particles
MAHE, SEYCHELLES / ACCESSWIRE / May 22, 2021 / Vendetta Capital is immensely pleased to…
Month: May 2021
PrivacySwap- To Develop a PRV-Accepting Debit Card
SINGAPORE / ACCESSWIRE / May 22, 2021 / PrivacySwap aims to develop a debit card that…
Hoppy Meme – Using the Meme Revolution to Create a Platform for Supporting a Sustainable Earth
ZUG, SWITZERLAND / ACCESSWIRE / May 22, 2021 / A few days after its launch,…
Hokk Finance – Generate Returns With Automated Farming While Working on a P2P System
GEORGETOWN, CAYMAN ISLANDS / ACCESSWIRE / May 22, 2021 / With the changing tide in the…
Occam.fi Unveils the OccamX DEX
ZUG, SWITZERLAND / ACCESSWIRE / May 21, 2021 / Today, the Occam Association is proudly…
Teligent, Inc. to Hold Conference Call for First Quarter 2021 Financial Results on Tuesday May 25, 2020
BUENA, N.J., May 21, 2021 (GLOBE NEWSWIRE) — Teligent, Inc. (Nasdaq: TLGT), (“Teligent” or the “Company”),…
Pacific Biosciences Grants Equity Incentive Award to New Employee
MENLO PARK, Calif., May 21, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ:…
Genmab Announces that Janssen has been Granted U.S. FDA Approval for RYBREVANT™ (amivantamab-vmjw) for Patients with Metastatic Non-small Cell Lung Cancer with Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion Mutations
Media Release Copenhagen, Denmark, May 21, 2021 Janssen Biotech, Inc. (Janssen) received U.S. FDA approval…
Syneos Health to Present at Upcoming Investor Conferences
MORRISVILLE, N.C., May 21, 2021 (GLOBE NEWSWIRE) — Syneos Health® (Nasdaq:SYNH), the only fully integrated…
AB Science will host a live webcast on Tuesday May 25, 2021 on masitinib results in Prostate Cancer
PRESS RELEASE AB SCIENCE WILL HOST A LIVE WEBCAST ON TUESDAY MAY 25, 2021 ON…
Madrigal Pharmaceuticals to Participate in UBS Global Healthcare Virtual Conference
WEST CONSHOHOCKEN, Pa., May 21, 2021 (GLOBE NEWSWIRE) — Madrigal Pharmaceuticals, Inc (NASDAQ: MDGL), a…
CORRECTION — EMA Issues Positive Scientific Opinion on GSK and Vir Biotechnology’s Sotrovimab For the Early Treatment of COVID-19
– Opinion based on the EMA’s Committee for Human Medicinal Products (CHMP) review of available…
Athenex Announces Klisyri® (tirbanibulin) Receives Positive CHMP Opinion from the European Medicines Agency (EMA) for the Treatment of Actinic Keratosis of the Face or Scalp
European Commission Decision Anticipated by July 2021 BUFFALO, N.Y., May 21, 2021 (GLOBE NEWSWIRE) —…
Larimar Therapeutics Announces $95 Million Private Placement Financing
BALA CYNWYD, Pa., May 21, 2021 (GLOBE NEWSWIRE) — Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR),…
Genmab Announces that Janssen has Received Positive CHMP Opinion Recommending DARZALEX® (daratumumab) Subcutaneous (SC) Formulation for Patients with Newly Diagnosed Light-chain (AL) Amyloidosis
Company Announcement Janssen received a positive CHMP opinion for DARZALEX® SC (daratumumab and hyaluronidase-fihj) in…
Rhythm Pharmaceuticals Receives Positive CHMP Opinion for Setmelanotide for Treatment of Obesity and Control of Hunger Associated with POMC, PCSK1 and LEPR Deficiency
European Commission decision anticipated in July BOSTON, May 21, 2021 (GLOBE NEWSWIRE) — Rhythm Pharmaceuticals,…
Albireo Receives Positive CHMP Opinion for Bylvay™ (odevixibat) for Treatment of Progressive Familial Intrahepatic Cholestasis (PFIC)
– Bylvay has the potential to become first approved drug to treat all forms of…
Zymergen to Present at UBS Global Healthcare Virtual Conference
EMERYVILLE, Calif., May 21, 2021 (GLOBE NEWSWIRE) — Biofacturing leader Zymergen today announced the company will…
Myovant Sciences Receives Positive CHMP Opinion for RYEQO® (Relugolix Combination Tablet) for the Treatment of Women With Uterine Fibroids
CHMP opinion recommending approval based on data from the Phase 3 LIBERTY program in women…
Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Brings Best-in-Class Team to Psychedelics Development
NEW YORK, May 21, 2021 (GLOBE NEWSWIRE) — NetworkNewsAudio – Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB:…